19 results on '"Davidson, Michael H."'
Search Results
2. ORTICUMAB, AN ANTIBODY AGAINST A SPECIFIC OXIDIZED LOW-DENSITY LIPOPROTEIN (OXLDL) EPITOPE, REDUCES CORONARY INFLAMMATION IN HIGH-RISK PATIENTS WITH PSORIASIS: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL.
3. Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease.
4. Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial.
5. Safety of Aggressive Lipid Management
6. Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density Lipoprotein Cholesterol Levels
7. Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density LipoproteinCholesterolLevelsonaBackgroundofAtorvastatin
8. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
9. Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein, Apolipoprotein, or Low-Density Lipoprotein Particle: What Should Clinicians Measure?*
10. Apolipoprotein A-I therapy promise, challenges, and disappointment.
11. Apolipoprotein A-I Therapy: Promise, Challenges, and Disappointment ⁎ [⁎] Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
12. Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia
13. RESULTS FROM THE FENOFIBRIC ACID ON CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS WITH TYPE IIB DYSLIPIDEMIA WITH RESIDUAL RISK IN ADDITION TO ATORVASTATIN THERAPY (FIRST) TRIAL
14. The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent: The Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
15. ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease
16. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
17. CAROTID ADVENTITIAL NEOVASCULARIZATION AND INTIMA–MEDIA THICKNESS AS MARKERS OF ATHEROGENESIS: EVIDENCE FROM TWO RANDOMIZED CONTROLLED TRIALS
18. A HIGHLY BIOAVAILABLE OMEGA-3 FREE-FATTY ACID REDUCES NON-HIGH DENSITY LIPOPROTEIN CHOLESTEROL IN HIGH-RISK PATIENTS TREATED WITH A STATIN AND RESIDUAL HYPERTRIGLYCERIDEMIA (ESPRIT TRIAL)
19. Effect of contrast enhancement on measurement of carotid artery intimal medial thickness
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.